跳至主要内容
临床试验/NCT02693951
NCT02693951Unknown不适用

Efficiency and Safety of Prophylactic Use of Antibiotics in Endoscopic Injection of Tissue Adhesive in Gastric Varices: A Randomized Controlled Trial

Shanghai Zhongshan Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2016年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
1
主要终点
The incidence of infection after endoscopic treatment

研究概览

简要总结

The purpose of the study is to assess the efficiency and safety of prophylactic use of antibiotics in endoscopic injection of tissue adhesive in gastric varices.

详细描述

At present, there is still a controversy about the application of antibiotics in the treatment of patients with non acute hemorrhage of esophageal varices. This study is a randomized controlled trial. Patients randomly enter two treatment groups:

  1. the prophylactic use of antibiotics group

and 2. the non-prophylactic use of antibiotics group

Treatment allocation is by block randomization with an equal number for both groups. The incidence of infection after endoscopic treatment will be analyzed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Capable of understanding the purpose and risks of the study and informed consent to participate in the study;
  • age between 18-75 years old;
  • Diagnosis of esophageal gastric varices by gastroscopy
  • Preparation of endoscopic injection of tissue adhesive

排除标准

  • No esophageal gastric varices bleeding history;
  • Esophageal varices or gastric varices which temporarily won't be treated by endoscopic therapy;
  • The cefotiam contraindications: such as allergies, pregnancy etc;
  • Patients with the other malignant tumor except liver cancer;
  • The preoperative diagnosis of infection;
  • The large amount of ascites;
  • The acute bleeding period (< 5 days);
  • Patients refused to participate in the study.

研究组 & 干预措施

the prophylactic use of antibiotics group

Experimental

Half an hour before endoscopic treatment, cefotiam 2.0g intravenous

干预措施: Cefotiam (Drug)

结局指标

主要结局

The incidence of infection after endoscopic treatment

时间窗: 1 week

Patients will receive body temperature, blood routine, inflammatory markers examination before and after endoscopic treatment.

次要结局

  • Rebleeding rate(2 months)
  • Mortality rate(2 months)

研究者

发起方
Shanghai Zhongshan Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Shiyao Chen

Director of department of Gastroenterology, Zhongshan Hospital

Shanghai Zhongshan Hospital

研究点 (1)

Loading locations...

相似试验

Efficiency and Safety of Prophylactic Use of... | 临床试验